Navigation Links
Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies
Date:7/27/2010

BOZEN, SUD-TIROL, Italy, July 27, 2010 /PRNewswire/ -- Health Robotics announced that it has reached final agreements to acquire all assets from Italy-based MEDarchiver S.r.l. and Biomedical Technology Consulting S.r.l., merging these companies' employees and operations, re-entering direct sales activities in the Italian market, and conducting a re-organization of its Executive Management, expecting to close these acquisitions over the next few months.

"After Health Robotics' meteoric growth recently surpassed the significant milestone of 100 worldwide I.V. Automation contracts, it dictated the need to consolidate its market gains by acquiring the assets of these two strategic partner companies that supplied products and services to Health Robotics' customers and to the I.V. Room of the Future Project. These acquisitions enable Health Robotics to: a) re-establish an IV Room presence in Italy after having temporarily exited the market in 2008 as a result of the transfer to Loccioni [CytoCare's development partner] of most of Italy's CytoCare operations; b) yield long-term cost synergies; and c) consolidate the three companies' intellectual property, customer-facing operations, and scientific knowledge within the fields of I.V. Automation and Clinical Workflow Solutions," stated Werner Rainer, Health Robotics' CEO.

MEDarchiver has built an outstanding reputation over the past decade for excellence in developing and implementing "All-Digital" life-critical software automation solutions for healthcare providers with exceptional innovation, ease-of-deployment, and R.O.I. results. Amongst others, assets include Cardio Web, the world's first and only nationwide Cardiology digital medical record, certified by the National Council of Cardiologists in Italy; OMM, which will serve as the company's cornerstone to expand its Cancer Therapy presence in North America, complementing CytoCare and i.v.SOFT; and MEDtpn, which enables Health Robotics to immediately offer TPN e-Prescription to its customers, and to develop TPNstation on top of an industrial-strength TPN workflow software foundation.

In anticipation of these acquisitions, Health Robotics' instituted in May and June 2010 changes to its Executive Management Team in order to have its members become more focused in specific areas of competence. Consequently, Fabio Fioravanti [Executive VP for Operations and CTO] assumed in June all responsibilities encompassing quality assurance, product development, implementation, operations, manufacturing, and customer support; Gaspar DeViedma ceased his General Counsel duties last May to focus exclusively on sales, product marketing, and joint-development activities worldwide, including MEDarchiver solutions outside of Italy; Paolo Giribona now exclusively concentrates on research activities related to new products such as TPNstation; and finally Werner Rainer continues as CEO of Health Robotics while exclusively centering his efforts on the I.V. Room of the Future, utilizing MEDarchiver's customer base to re-enter the Italian market for I.V. Automation, and directly supervising the newly formed 10-member Health Robotics' Scientific Advisory Board, whose contributors will be announced in August 2010.

Biomedical Technology Consulting has led technology assessments and workflow re-design projects in Italy, Germany, France, Luxemburg, Switzerland, Croatia, Serbia, Romania, Albania, U.A.E., Qatar, Iraq, Cyprus, and Vietnam, with extensive experience in the I.V. Room, Pharmacy, Cardiology, Anesthesiology, PACS, and Nursing segments.

Expected immediate synergies from the merged companies include a single customer help-desk; integrated R&D, quality assurance and production teams; one-stop distribution channels; and the acquisition of key personnel assets. MEDarchiver will continue to operate as a division of Health Robotics, focusing on integrated and "All-Digital" workflow automation solutions in its established local markets, while benefiting from exporting best-of-class Oncology, Cardiology and other medical error-avoidance technology solutions throughout Health Robotics' worldwide distribution network. Health Robotics will continue investing into and expanding MEDarchiver markets, and showcasing its "All-Digital" healthcare installations, such as Campus Biomedico University Hospital and La Maddalena Cancer Institute. For more information, please visit: http://www.medarchiver.com

About Health Robotics:

Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing healthcare facilities in 5 continents with robotics technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [manual compounding software], MEDarchiver(TM) [clinical information system], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug-exchange errors, decrease other medical errors and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff.

For more company information including a corporate video, please visit http://www.health-robotics.com/en/about-health-robotics/. For additional information, please contact:

    Health Robotics S.r.l.
    Claudia Flaim, Marketing Coordinator
    Phone: +39-0471-200-372
    flaim@health-robotics.com


'/>"/>
SOURCE Health Robotics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
Breaking Medicine News(10 mins):